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Abstract
Aims/hypothesis—Women with a history of gestational diabetes mellitus (GDM) are advised 
to control their weight after pregnancy. We aimed to examine how adiposity and weight change 
influence the long-term risk of developing type 2 diabetes after GDM.
Methods—We included 1,695 women who had incident GDM between 1991 and 2001, as part 
of the Diabetes & Women’s Health study, and followed them until the return of the 2009 
questionnaire. Body weight and incident type 2 diabetic cases were reported biennially. We 
defined baseline as the questionnaire period when women reported an incident GDM pregnancy. 
We estimated HRs and 95% CIs using Cox proportional hazards models.
Results—We documented 259 incident cases of type 2 diabetes during up to 18 years of follow-
up. The adjusted HRs of type 2 diabetes associated with each 1 kg/m2 increase in BMI were 1.16 
(95% CI 1.12, 1.19) for baseline BMI and 1.16 (95% CI 1.13, 1.20) for most recent BMI. 
Moreover, each 5 kg increment of weight gain after GDM development was associated with a 
27% higher risk of type 2 diabetes (adjusted HR 1.27; 95% CI 1.04, 1.54). Jointly, women who 
had a BMI ≥30.0 kg/ m2 at baseline and gained ≥5 kg after GDM had an adjusted HR of 43.19 
(95% CI 13.60, 137.11), compared with women who had a BMI <25.0 kg/m2 at baseline and 
gained <5 kg after GDM.
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Conclusions/interpretation—Baseline BMI, most recent BMI and weight gain after GDM 
were significantly and positively associated with risk of progression from GDM to type 2 diabetes.
Keywords
BMI; Gestational diabetes mellitus; Type 2 diabetes mellitus; Weight change
Introduction
Gestational diabetes mellitus (GDM) is a common pregnancy complication defined as 
glucose intolerance with onset or first recognition during pregnancy [1]. Women who 
develop GDM during pregnancy probably have reduced insulin secretion and/or chronic 
insulin resistance before pregnancy [2, 3]. As a result, they are at substantially increased risk 
of developing type 2 diabetes later in life [4]. One-third of women with type 2 diabetes were 
found to have a history of GDM [5]. The increasing prevalence of GDM [6–8] parallels the 
worldwide epidemic of type 2 diabetes [9]. Women with a history of GDM represent a 
‘revealed’ high-risk group for type 2 diabetes [10], because GDM cases are routinely 
identified through blood glucose testing between 24 and 28 weeks of gestation [1]. It 
remains to be elucidated whether the natural course of the progression from GDM to overt 
type 2 diabetes is significantly altered by lifestyle factors.
Excess adiposity and weight gain are well-documented risk factors of type 2 diabetes in the 
general population [11–15]. Compared with the general population, women who develop 
GDM are more likely to be overweight or obese at the time of GDM diagnosis and are more 
likely to develop incident overweight or obesity in later life [16]. As a result, women with a 
history of GDM are usually advised to control their weight after delivery [1, 16]. The 
National Diabetes Education Program (NDEP) recently called for women with a history of 
GDM to be referred to a registered dietitian or community programme for weight 
management [17]. A similar recommendation was also given by the American Diabetes 
Association (ADA) [1]. Despite these recommendations, weight gain is common among 
women with a history of GDM after the index pregnancy and throughout their lifespan [16, 
18]. The long-term risk of type 2 diabetes in association with adiposity and weight change 
among women with a history of GDM has not been clearly characterised [19].
In this study, we used data from the Nurses’ Health Study (NHS) II cohort to examine the 
associations of BMI at baseline and follow-up, as well as weight change after GDM, with 
long-term risk of type 2 diabetes among women with a history of GDM.
Methods
Study population
The study population was composed of women with a history of GDM in NHS II, as part of 
the ongoing Diabetes & Women’s Health study [20], which aims to identify determinants of 
the progression from GDM to type 2 diabetes. NHS II, established in 1989, is an ongoing 
prospective cohort study of 116,671 female nurses aged 25–44 years at study initiation [21]. 
Participants receive a biennial questionnaire to update information on health-related 
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behaviours and disease outcomes. The follow-up rate for each questionnaire cycle was 
greater than 90% up to 2009. This study was approved by the Partners Human Research 
Committee (Boston, MA, USA), with participants’ consent implied by the return of the 
questionnaires.
Women were eligible for inclusion if they reported incident GDM from 1991 to 2001. They 
were followed up until the return of the 2009 questionnaire. The 2001 questionnaire was the 
last time questions regarding GDM were included, as the majority of NHS II participants 
had passed reproductive age by then. In a prior validation study, 94% of self-reported GDM 
cases were confirmed by medical records [21]. In a random sample of parous women 
without GDM, 83% reported a glucose screening test during pregnancy and 100% reported 
frequent prenatal urine screening, suggesting a high level of GDM surveillance in this cohort 
[21]. We excluded women from the analytical population if they had: (1) prevalent GDM in 
1989; (2) type 2 diabetes, cardiovascular disease or cancer prior to their GDM pregnancy or 
before the return of their first post-GDM questionnaire; or (3) a multiple gestation (twins or 
triplets). Electronic supplementary material (ESM) Fig. 1 briefly outlines the data collection 
and follow-up of the study population.
Assessment of exposures
The NHS II participants reported their weight and height in the 1989 questionnaire and they 
further updated their current weight on each biennial questionnaire. Only 2–4% of the study 
participants who responded to the questionnaire had missing data on body weight across the 
follow-up years. Self-reported weight was highly correlated with technician-measured 
weight (r=0.97) among a subset of NHS cohort participants [22]. BMI was computed as 
weight in kilograms divided by the square of height in metres (kg/m2). We classified the 
participants’ BMI into the categories <18.5, 18.5–24.9, 25.0–29.9, 30.0–34.9, 35.0–39.9 and 
≥40.0 kg/m2, corresponding to definitions of underweight, normal weight, overweight, class 
I obesity, class II obesity and class III obesity, respectively, according to National Institutes 
of Health guidelines [23]. Since only 1% of the participants had a BMI <18.5 kg/m2, we 
merged this category and 18.5–24.9 kg/m2 into BMI <25.0 kg/m2 to ensure statistical power 
in the present analysis.
Information on age, smoking status, age at first birth, reproductive history, oral 
contraceptive use and menopausal status was biennially updated from 1989. Parity was 
defined as the number of pregnancies lasting greater than 6 months. Race/ethnicity data 
were collected in 1989, and family history of diabetes was collected in 1989 and updated in 
2005. Diet information was updated every 4 years since 1991 using a semi-quantitative food 
frequency questionnaire (FFQ). The FFQ is designed to measure average dietary intake over 
the past year and has been extensively validated [24–26]. To characterise overall diet 
quality, we created a summary diet score in terms of the Alternate Healthy Eating Index 
2010 (AHEI), as previously described [27]. Total physical activity was ascertained in 1991, 
1997 and every 4 years thereafter by frequency of engaging in common recreational 
activities, from which metabolic equivalent task-hours per week were derived. The 
questionnaire-based estimates correlated well with detailed activity diaries in a prior 
validation study (r=0.56) [28].
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Participants reporting physician-diagnosed type 2 diabetes on each biennial questionnaire 
were mailed a supplemental questionnaire regarding symptoms, diagnostic tests and 
hypoglycaemic therapy to confirm self-reported diagnoses. Confirmed diabetes required at 
least one of the following reported on the supplementary questionnaire according to ADA 
criteria [29]: (1) one or more classic symptoms (excessive thirst, polyuria, weight loss, 
hunger, pruritus or coma) plus elevated glucose levels (fasting plasma glucose concentration 
≥7.0 mmol/l or random plasma glucose ≥11.1 mmol/l); or (2) no symptoms reported but two 
or more elevated plasma glucose concentrations on more than one occasion (fasting ≥7.0 
mmol/l, random ≥11.1 mmol/l, 2 h OGTT ≥11.1 mmol/l); or (3) treatment with insulin or an 
oral hypoglycaemic agent. Before 1998, fasting plasma glucose ≥7.8 mmol/l was used 
instead of ≥7.0 mmol/l for the diagnosis of diabetes according to the criteria of the National 
Diabetes Data Group (NDDG) [30]. In a previous validation study [31], high accuracy 
(98%) was observed comparing our classification with medical records according to NDDG 
criteria. In a second validation study conducted in 1999, the diagnosis of type 2 diabetes was 
confirmed by medical record reviews according to ADA criteria, with high validity (99%).
Statistical analysis
In this analysis, baseline was defined as the questionnaire period when women reported an 
incident GDM pregnancy during 1991–2001. Therefore, baseline weight was within 2 years 
after GDM diagnosis. Weight change since baseline was defined as the most recent body 
weight at follow-up minus baseline body weight. We computed follow-up time from the 
date of diagnosis of GDM to the date of diagnosis of type 2 diabetes, death, last biennial 
questionnaire response or return of the 2009 questionnaire, whichever came first. Updating 
of exposure status ceased if a participant reported a diagnosis of chronic disease (e.g. 
cardiovascular disease, cancer), because such diagnoses may lead to unintentional or 
intentional changes in body weight. If exposure data were missing in one questionnaire 
cycle, the values were carried forward from the previous questionnaire for which the data 
were captured. However, missing exposure data were not carried forward and were therefore 
excluded in the analysis of weight change.
We estimated HRs and 95% CIs using Cox proportional hazards models stratified by time 
since GDM diagnosis. We conducted tests of linear trend across categories of BMI or weight 
change by assigning the median value for each category and fitting this continuous variable 
in the models. In the multivariable analysis estimating the effect of updated BMI (i.e. most 
recent BMI within 2 years before diagnosis of type 2 diabetes), we adjusted for various 
potential confounding factors, including age, parity, age at first birth, race/ethnicity, family 
history of diabetes, oral contraceptive use, menopausal status, cigarette smoking, 
breastfeeding duration, total energy intake, diet quality (i.e. AHEI score) and physical 
activity. All these covariates except race/ethnicity were updated over time. For the analysis 
assessing baseline BMI in relation to risk of type 2 diabetes, we adjusted for the baseline 
measures of the above variables. To evaluate weight change after GDM in association with 
risk of type 2 diabetes, we adjusted for baseline BMI, the aforementioned potential 
confounding factors, and simultaneous changes in lifestyle factors, including smoking status 
(never to never, never to current, past to past, past to current, current to past, current to 
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current), as well as baseline and changes in breastfeeding duration, parity, total energy 
intake, diet quality (i.e. AHEI score) and physical activity. Categorical covariates included 
an indicator for missing data, if necessary.
We evaluated potential effect modification by stratified analyses according to age (<40 years 
or ≥40 years), family history of diabetes (yes/no), diet quality (AHEI score, above or below 
the median), physical activity (above or below the median), breastfeeding duration (<6 
months or ≥6 months) and time since GDM pregnancy (<10 or ≥10 years). To address the 
potential bias by medical surveillance for type 2 diabetes, we conducted a sensitivity 
analysis restricting the definition of type 2 diabetic cases to participants reporting at least 
one diabetic symptom at the time of diagnosis. To min-imise potential bias from subclinical 
type 2 diabetes leading to unintentional weight loss, we conducted additional analyses in 
which we excluded women who reported type 2 diabetes in the subsequent questionnaire 
after reporting GDM: for example, when a woman reported GDM in 1991 and type 2 
diabetes in 1993. All statistical analyses were performed using SAS software (version 9.3; 
SAS Institute, Cary, NC, USA). A p value <0.05 was considered statistically significant.
Results
During up to 18 years of follow-up (18,596 person-years), we documented 259 incident 
cases of type 2 diabetes among 1,695 women with a history of GDM. The mean follow-up 
duration was 13.1 years (median 14.0 years). At baseline, women with higher BMI were 
older, less physically active and more likely to have a family history of diabetes. They had 
lower diet quality and shorter breastfeeding duration (Table 1). During follow-up, we 
observed an average weight gain of 0.47 kg per year after the index GDM pregnancy.
Both baseline and updated BMI were strongly and positively associated with future risk of 
type 2 diabetes. Figure 1 depicts the unadjusted cumulative incidence of type 2 diabetes 
according to baseline BMI. After adjustment for age, parity and other major diabetic risk 
factors, women who had a baseline BMI 25.0–29.9, 30.0–34.9, 35.0–39.9 and ≥40.0 kg/m2, 
compared with women having a baseline BMI <25.0 kg/m2, had adjusted HRs of 3.62 (95% 
CI 2.22, 5.91), 6.72 (95% CI 3.97, 11.37), 15.28 (95% CI 8.52, 27.41) and 17.28 (95% CI 
8.63, 34.60), respectively (p for linear trend <0.001). When baseline BMI was modelled as a 
continuous variable, each 1 kg/m2 increase in baseline BMI was associated with a 16% 
higher risk of type 2 diabetes (HR 1.16; 95% CI 1.12, 1.19) (Table 2; ESM Fig. 2). A similar 
association of type 2 diabetic risk was observed for updated BMI. Women with an updated 
BMI of 25.0–29.9, 30.0–34.9, 35.0–39.9 and ≥40.0 kg/m2, compared with women with an 
updated BMI of <25.0 kg/m2, had adjusted HRs of 3.82 (95% CI 2.08, 7.03), 9.69 (95% CI 
5.17, 18.16), 14.68 (95% CI 7.47, 28.88) and 25.97 (95% CI 12.62, 53.44), respectively. The 
adjusted HR of type 2 diabetes associated with each increment of 5 kg/m2 in updated BMI 
was 1.16 (95% CI 1.13, 1.20).
Weight gain after GDM was significantly associated with risk of type 2 diabetes (Table 3). 
After adjustment for baseline BMI and other major diabetic risk factors, the adjusted HRs of 
type 2 diabetes associated with weight gain of 2.6–4.9, 5.0–9.9 and ≥10.0 kg were 1.17 
(95% CI 0.53, 2.56), 1.48 (95% CI 0.72, 3.03) and 1.99 (95% CI 0.94, 4.25), respectively (p 
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for linear trend=0.02), compared with maintaining a stable body weight (±2.5 kg) since 
baseline. An increment of 5 kg weight gain after GDM development was associated with a 
27% higher risk of type 2 diabetes (HR 1.27; 95% CI 1.04, 1.54). In the analysis of joint 
effect of baseline BMI and subsequent weight gain on risk of type 2 diabetes, women who 
had a BMI ≥30.0 kg/m2 at baseline and gained ≥5 kg after GDM had an adjusted HR of 
43.19 (95% CI 13.60, 137.11), compared with women who had a BMI <25.0 kg/m2 at 
baseline and gained <5 kg after GDM (Fig. 2).
The positive associations of BMI and weight change with risk of type 2 diabetes persisted 
across different categories of age, family history of diabetes, diet quality, physical activity, 
breastfeeding duration and time since GDM pregnancy. Moreover, the observed associations 
were robust in multiple sensitivity analyses. First, to minimise potential bias from 
subclinical type 2 diabetes before GDM diagnosis, we conducted a sensitivity analysis by 
excluding women who reported type 2 diabetes in the next questionnaire after reporting 
GDM, and found that the multivariable-adjusted HRs across categories of BMI or weight 
change were not appreciably changed. Second, sensitivity analyses restricted to women 
reporting at least one symptom of diabetes at diagnosis yielded similar results to those for all 
cases.
Discussion
In this prospective cohort study with up to 18 years of follow-up, we found that both initial 
BMI within 2 years after diagnosis of GDM and the most recent BMI before diagnosis of 
type 2 diabetes were positively and strongly associated with a greater risk of type 2 diabetes 
among women with a history of GDM. Moreover, we observed that weight gain after GDM 
was significantly associated with risk of type 2 diabetes. These associations were 
independent of other major risk factors of type 2 diabetes, including lifestyle factors such as 
diet and physical activity.
The associations of BMI and weight change with risk of type 2 diabetes among women with 
a history of GDM, a population at high risk of type 2 diabetes, have not been 
comprehensively examined. A subgroup analysis of the Diabetes Prevention Program (DPP) 
randomised clinical trial showed that intensive lifestyle intervention including diet, physical 
activity and weight loss reduced the incidence of type 2 diabetes over 3 years among women 
with impaired glucose tolerance and a history of GDM [32]. Although another analysis from 
the overall DPP population showed that weight loss was the predominant predictor of 
diabetic risk reduction, independently of diet and physical activity [33], it was unclear 
whether that was the case in a high-risk population who may have reduced insulin secretion 
and/or chronic insulin resistance before pregnancy, i.e. women with a history of GDM. In 
the present study, we observed significant associations of BMI and weight change with the 
risk of progression from GDM to type 2 diabetes, which were independent of a healthful 
dietary pattern and physical activity, two major modifiable risk factors that have been 
inversely associated with risk of type 2 diabetes among women with a history of GDM [34, 
35]. Furthermore, our findings support the recent call to action from the NDEP which 
underlines the importance of postpartum weight management after GDM [17].
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Our findings were consistent with those of previous reports among women with a history of 
GDM that examined the associations of risk of type 2 diabetes with baseline BMI before 
pregnancy or shortly after the GDM pregnancy [36–41], most recent BMI [42] and weight 
change since baseline [37, 40, 43]. With longitudinal data on body weight, type 2 diabetic 
status and other major diabetic risk factors, which may be potential confounders, during 18 
years of follow-up, our study had the unique opportunity to comprehensively examine the 
long-term risk of exposures including BMI, weight change and their joint effects on 
progression from GDM to type 2 diabetes. Our findings highlight the importance of 
controlling both initial weight and weight gain in the prevention of type 2 diabetes among 
women with a history of GDM.
Strengths of this study include its prospective cohort design, long-term follow-up, the high 
response rate of each questionnaire cycle, and comprehensive data that were longitudinally 
collected over decades. In addition, the NHS II participants are registered nurses, reducing 
potential confounding by educational attainment or differential access to healthcare. We 
acknowledge that there are limitations. First, body weight was self-reported in this study. 
However, self-reported weight was previously validated against technician-measured weight 
with a high correlation (r=0.97) among a subset of NHS cohort participants [22]. 
Nonetheless, because of the prospective nature of the study design, misclassifications of the 
exposure would be non-differential. As such, the observed associations of BMI and weight 
gain with type 2 diabetes were more likely to be underestimated. The outcome, physician-
diagnosed type 2 diabetes, was also on the basis of self-report. However, it was confirmed 
by supplemental questionnaires including diabetes-related symptoms, glucose testing and 
glucose-lowering treatments. Specifically, in the study population of US female nurses, 98% 
of self-reported type 2 diabetic events were confirmed by medical records [31]. Second, 
BMI may not be able to accurately define obesity, in particular body fat distribution [44]. 
However, a previous meta-analysis of 32 studies has shown that although the clinical 
perspective focusing on central obesity is appealing, BMI and central obesity indicators have 
similar associations with incident diabetes [45]. Third, our study population consists mostly 
of white American women, thus the generalisation of our findings to other ethnic groups 
needs further evaluation. Fourth, screening bias may exist, because women who were more 
health-conscious, and therefore visited a physician more regularly, might have been more 
likely to receive a medical diagnosis than those who were less health-conscious. However, 
we found similar results in our sensitivity analyses restricting cases to symptomatic type 2 
diabetes, minimising concerns for this bias.
In conclusion, among women with a history of GDM, we observed significant and positive 
associations of risk of type 2 diabetes with initial BMI within 2 years after diagnosis of 
GDM, the most recent BMI before diagnosis of type 2 diabetes and weight gain after GDM. 
Our findings provide evidence to support the recent call from NDEP and highlight the 
importance of achieving and maintaining a healthy weight in these high-risk women to 
prevent future development of type 2 diabetes.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
Bao et al. Page 8














Funding This study was supported by the Intramural Research Program of the Eunice Kennedy Shriver National 
Institute of Child Health and Human Development, National Institutes of Health (contract no. 
HHSN275201000020C). NHS II was funded by research grants DK58845, CA50385, P30 DK46200 and UM1 
CA176726 from the National Institutes of Health. DKT was supported by a mentored fellowship from the ADA 
(no. 7-12-MN-34).
Abbreviations
ADA American Diabetes Association
AHEI Alternate Healthy Eating Index 2010
DPP Diabetes Prevention Program
FFQ Food frequency questionnaire
GDM Gestational diabetes mellitus
NDDG National Diabetes Data Group
NDEP National Diabetes Education Program
NHS Nurses’ Health Study
References
1. American Diabetes Association. Gestational diabetes mellitus. Diabetes Care. 2004; 27(Suppl 
1):S88–S90. [PubMed: 14693936] 
2. Buchanan TA, Xiang AH, Page KA. Gestational diabetes mellitus: risks and management during 
and after pregnancy. Nat Rev Endocrinol. 2012; 8:639–649. [PubMed: 22751341] 
3. Kim C. Maternal outcomes and follow-up after gestational diabetes mellitus. Diabet Med. 2014; 
31:292–301. [PubMed: 24341443] 
4. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational 
diabetes: a systematic review and meta-analysis. Lancet. 2009; 373:1773–1779. [PubMed: 
19465232] 
5. Cheung NW, Byth K. Population health significance of gestational diabetes. Diabetes Care. 2003; 
26:2005–2009. [PubMed: 12832303] 
6. Ferrara A, Kahn HS, Quesenberry CP, Riley C, Hedderson MM. An increase in the incidence of 
gestational diabetes mellitus: Northern California, 1991–2000. Obstet Gynecol. 2004; 103:526–533. 
[PubMed: 14990417] 
7. Getahun D, Nath C, Ananth CV, Chavez MR, Smulian JC. Gestational diabetes in the United States: 
temporal trends 1989 through 2004. Am J Obstet Gynecol. 2008; 198(525):e521–e525.
8. Zhang F, Dong L, Zhang CP, et al. Increasing prevalence of gestational diabetes mellitus in Chinese 
women from 1999 to 2008. Diabet Med. 2011; 28:652–657. [PubMed: 21569085] 
9. Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus—
present and future perspectives. Nat Rev Endocrinol. 2012; 8:228–236. [PubMed: 22064493] 
10. Bentley-Lewis R. Gestational diabetes mellitus: an opportunity of a lifetime. Lancet. 2009; 
373:1738–1740. [PubMed: 19465213] 
11. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes 
mellitus in women. Ann Intern Med. 1995; 122:481–486. [PubMed: 7872581] 
12. Ford ES, Williamson DF, Liu S. Weight change and diabetes incidence: findings from a national 
cohort of US adults. Am J Epidemiol. 1997; 146:214–222. [PubMed: 9247005] 
Bao et al. Page 9













13. Resnick HE, Valsania P, Halter JB, Lin X. Relation of weight gain and weight loss on subsequent 
diabetes risk in overweight adults. J Epidemiol Community Health. 2000; 54:596–602. [PubMed: 
10890871] 
14. Will JC, Williamson DF, Ford ES, Calle EE, Thun MJ. Intentional weight loss and 13-year 
diabetes incidence in overweight adults. Am J Public Health. 2002; 92:1245–1248. [PubMed: 
12144977] 
15. Langenberg C, Sharp SJ, Schulze MB, et al. Long-term risk of incident type 2 diabetes and 
measures of overall and regional obesity: the EPIC-InterAct case-cohort study. PLoS Med. 2012; 
9:e1001230. [PubMed: 22679397] 
16. Ratner RE. Prevention of type 2 diabetes in women with previous gestational diabetes. Diabetes 
Care. 2007; 30(Suppl 2):S242–S245. [PubMed: 17596479] 
17. Gabbe SG, Landon MB, Warren-Boulton E, Fradkin J. Promoting health after gestational diabetes: 
a National Diabetes Education Program call to action. Obstet Gynecol. 2012; 119:171–176. 
[PubMed: 22183225] 
18. Ferrara A, Hedderson MM, Albright CL, et al. A pregnancy and postpartum lifestyle intervention 
in women with gestational diabetes mellitus reduces diabetes risk factors: a feasibility randomized 
control trial. Diabetes Care. 2011; 34:1519–1525. [PubMed: 21540430] 
19. Baptiste-Roberts K, Barone BB, Gary TL, et al. Risk factors for type 2 diabetes among women 
with gestational diabetes: a systematic review. Am J Med. 2009; 122(207–214):e204.
20. Zhang C, Hu FB, Olsen SF, et al. Rationale, design, and method of the Diabetes & Women’s 
Health study—a study of long-term health implications of glucose intolerance in pregnancy and 
their determinants. Acta Obstet Gynecol Scand. 2014; 93:1123–1130. [PubMed: 24828694] 
21. Solomon CG, Willett WC, Carey VJ, et al. A prospective study of pregravid determinants of 
gestational diabetes mellitus. JAMA. 1997; 278:1078–1083. [PubMed: 9315766] 
22. Rimm EB, Stampfer MJ, Colditz GA, Chute CG, Litin LB, Willett WC. Validity of self-reported 
waist and hip circumferences in men and women. Epidemiology. 1990; 1:466–473. [PubMed: 
2090285] 
23. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of 
overweight and obesity in adults—the evidence report. Obes Res. 1998; 6(Suppl 2):51S–209S. 
[PubMed: 9813653] 
24. Willett WC, Reynolds RD, Cottrell-Hoehner S, Sampson L, Browne ML. Validation of a semi-
quantitative food frequency questionnaire: comparison with a 1-year diet record. J Am Diet Assoc. 
1987; 87:43–47. [PubMed: 3794132] 
25. Willett WC, Sampson L, Stampfer MJ, et al. Reproducibility and validity of a semiquantitative 
food frequency questionnaire. Am J Epidemiol. 1985; 122:51–65. [PubMed: 4014201] 
26. Salvini S, Hunter DJ, Sampson L, et al. Food-based validation of a dietary questionnaire: the 
effects of week-to-week variation in food consumption. Int J Epidemiol. 1989; 18:858–867. 
[PubMed: 2621022] 
27. Chiuve SE, Fung TT, Rimm EB, et al. Alternative dietary indices both strongly predict risk of 
chronic disease. J Nutr. 2012; 142:1009–1018. [PubMed: 22513989] 
28. Wolf AM, Hunter DJ, Colditz GA, et al. Reproducibility and validity of a self-administered 
physical activity questionnaire. Int J Epidemiol. 1994; 23:991–999. [PubMed: 7860180] 
29. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert 
Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997; 
20:1183–1197. [PubMed: 9203460] 
30. National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other 
categories of glucose intolerance. Diabetes. 1979; 28:1039–1057. [PubMed: 510803] 
31. Manson JE, Rimm EB, Stampfer MJ, et al. Physical activity and incidence of non-insulin-
dependent diabetes mellitus in women. Lancet. 1991; 338:774–778. [PubMed: 1681160] 
32. Ratner RE, Christophi CA, Metzger BE, et al. Prevention of diabetes in women with a history of 
gestational diabetes: effects of metformin and lifestyle interventions. J Clin Endocrinol Metab. 
2008; 93:4774–4779. [PubMed: 18826999] 
33. Hamman RF, Wing RR, Edelstein SL, et al. Effect of weight loss with lifestyle intervention on risk 
of diabetes. Diabetes Care. 2006; 29:2102–2107. [PubMed: 16936160] 
Bao et al. Page 10













34. Tobias DK, Hu FB, Chavarro J, Rosner B, Mozaffarian D, Zhang C. Healthful dietary patterns and 
type 2 diabetes mellitus risk among women with a history of gestational diabetes mellitus. Arch 
Intern Med. 2012; 172:1566–1572. [PubMed: 22987062] 
35. Bao W, Tobias DK, Bowers K, et al. Physical activity and sedentary behaviors associated with risk 
of progression from gestational diabetes mellitus to type 2 diabetes mellitus: a prospective cohort 
study. JAMA Intern Med. 2014; 174:1047–1055. [PubMed: 24841449] 
36. Lee AJ, Hiscock RJ, Wein P, Walker SP, Permezel M. Gestational diabetes mellitus: clinical 
predictors and long-term risk of developing type 2 diabetes: a retrospective cohort study using 
survival analysis. Diabetes Care. 2007; 30:878–883. [PubMed: 17392549] 
37. Liu H, Zhang C, Zhang S, et al. Prepregnancy body mass index and weight change on postpartum 
diabetes risk among gestational diabetes women. Obesity (Silver Spring). 2014; 22:1560–1567. 
[PubMed: 24616432] 
38. Schaefer-Graf UM, Klavehn S, Hartmann R, et al. How do we reduce the number of cases of 
missed postpartum diabetes in women with recent gestational diabetes mellitus? Diabetes Care. 
2009; 32:1960–1964. [PubMed: 19641163] 
39. Pirkola J, Pouta A, Bloigu A, et al. Prepregnancy overweight and gestational diabetes as 
determinants of subsequent diabetes and hypertension after 20-year follow-up. J Clin Endocrinol 
Metab. 2010; 95:772–778. [PubMed: 19952227] 
40. Egeland GM, Meltzer SJ. Following in mother’s footsteps? Mother–daughter risks for insulin 
resistance and cardiovascular disease 15 years after gestational diabetes. Diabet Med. 2010; 
27:257–265. [PubMed: 20536487] 
41. Ekelund M, Shaat N, Almgren P, Groop L, Berntorp K. Prediction of postpartum diabetes in 
women with gestational diabetes mellitus. Diabetologia. 2010; 53:452–457. [PubMed: 19957074] 
42. Cho NH, Jang HC, Park HK, Cho YW. Waist circumference is the key risk factor for diabetes in 
Korean women with history of gestational diabetes. Diabetes Res Clin Pract. 2006; 71:177–183. 
[PubMed: 16054264] 
43. Peters RK, Kjos SL, Xiang A, Buchanan TA. Long-term diabetogenic effect of single pregnancy in 
women with previous gestational diabetes mellitus. Lancet. 1996; 347:227–230. [PubMed: 
8551882] 
44. Okorodudu DO, Jumean MF, Montori VM, et al. Diagnostic performance of body mass index to 
identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes. 
2010; 34:791–799.
45. Vazquez G, Duval S, Jacobs DR Jr, Silventoinen K. Comparison of body mass index, waist 
circumference, and waist/ hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol 
Rev. 2007; 29:115–128. [PubMed: 17494056] 
Bao et al. Page 11














Unadjusted cumulative incidence of type 2 diabetes, according to baseline BMI, among 
women with a history of GDM. Red line, BMI <25.0 kg/m2; green line, BMI 25.0–29.9 
kg/m2; blue line, BMI 30.0–34.9 kg/m2; cyan line, BMI 35.0–39.9 kg/m2; purple line, BMI 
≥40.0 kg/m2
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Joint effect of baseline BMI and weight gain after GDM in association with long-term risk 
of progression from GDM to type 2 diabetes. White bars, weight gain <5 kg after GDM; 
grey bars, weight gain ≥5 kg after GDM. The error bars indicate 95% CIs. The reference 
group was women who had a BMI <25.0 kg/m2 at baseline and gained <5 kg after GDM 
(including weight loss and no change). Covariates in the multivariable model include: age 
(months), age at first birth (12–24, 25–29 or ≥30 years), race/ethnicity (white, African-
American, Hispanic, Asian, others), family history of diabetes (yes, no), oral contraceptive 
use (current, former, never), menopausal status (premenopausal, postmenopausal), change in 
cigarette smoking status (never to never, never to current, past to past, past to current, 
current to past, current to current), parity at baseline (1, 2, 3+), change in parity (0, 1, 2+), 
and baseline and changes (all in quartiles unless otherwise specified) in breastfeeding 
duration (<1, 1–5, 6–11, ≥12 months), total energy intake, diet quality (i.e. AHEI score) and 
physical activity
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